Skip to main content
. Author manuscript; available in PMC: 2016 Sep 12.
Published in final edited form as: JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1043–1051. doi: 10.1001/jamaoto.2015.1508

Table 1.

Patient and Tumor Characteristics

Characteristic Value (N = 410)a
Age, mean (SD), y 59.6 (10.8)

Sex

 Male 338 (82.4)

 Female 72 (17.6)

Smoking history

 Yes 224 (54.6)

 No 114 (27.8)

 Unknown 72 (17.6)

Alcohol use history

 Yes 166 (40.5)

 No 86 (21.0)

 Quit 50 (12.2)

 Unknown 108 (26.3)

Subsite

 Oropharynx 364 (88.8)

 Supraglottic larynx 24 (5.9)

 Hypopharynx 9 (2.2)

 Posterolateral oral cavity 9 (2.2)

 Other 4 (1.0)

Pathologic tumor stage

 Tx 18 (4.4)

 T0 12 (2.9)

 T1 170 (41.5)

 T2 172 (42.0)

 T3 28 (6.8)

 T4 10 (2.4)

Pathologic nodal stage

 N0 120 (29.2)

 N1 57 (13.9)

 N2a 64 (15.6)

 N2b 110 (26.8)

 N2c 16 (3.9)

 N3 7 (1.7)

 Nx 36 (8.8)

Positive margins

 Yes 39 (9.9)

 No 354 (86.3)

 Unknown 17 (4.1)

Close margins (1-5 mm)

 Yes 86 (21.0)

 No 170 (41.5)

 Not specified 154 (37.6)

Perineural invasion

 Yes 67 (16.3)

 No 234 (57.0)

 Not specified 109 (26.6)

Lymphovascular invasion

 Yes 78 (19.0)

 No 217 (52.9)

 Not specified 115 (28.0)

Multiple nodal positivity

 Yes 110 (26.8)

 No 241 (58.8)

 Unknown 59 (14.4)

Extracapsular spread

 Yes 58 (14.2)

 No 100 (24.4)

 Unknown 252 (61.5)

HPV status (229 patients tested)

 Negative 70 (17.1)

 Positive 159 (38.8)

 Unknown 181 (44.1)

p16 positivity (219 patients tested)

 Negative 61 (14.9)

 Positive 158 (38.5)

 Unknown 191 (46.6)

Neck dissection

 Yes 323 (78.8)

 No 77 (18.8)

 Unknown 10 (2.4)

Adjuvant treatment (338 patients)

 Radiotherapy 106 (25.9)

 Chemoradiotherapy 72 (17.6)

 No adjuvant treatment received 160 (39.0)

 Unknown 72 (17.6)

Abbreviation: HPV, human papillomavirus.

a

Data are presented as number (percentage) of patients unless otherwise indicated.